Every pharmaceutical company is talking about patient engagement. A greater focus on the patient gives way to valuable real-world data and insight into therapy performance and medication adherence. Pharmaceutical companies want to understand how patients respond to therapies to ultimately improve health outcomes.
Improved commercial strategies and models require access to better data. Unifying data across provider, patient, and partner information on a common platform gives all stakeholders a single view into valuable operational and customer insights.
Services that go “beyond the pill” help bolster revenue growth, especially in the face of drug patent expirations, generics, and biosimilar products entering the market.
Read more here.